TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12 | -45.5% | 18,077 | -33.9% | 0.00% | -50.0% |
Q1 2023 | $22 | -94.7% | 27,338 | -85.1% | 0.00% | -96.2% |
Q4 2022 | $416 | -99.9% | 183,857 | -22.1% | 0.05% | -13.3% |
Q3 2022 | $456,000 | -34.3% | 236,120 | +26.6% | 0.06% | -42.3% |
Q2 2022 | $694,000 | -9.2% | 186,480 | +59.2% | 0.10% | +1.0% |
Q1 2022 | $764,000 | +60.5% | 117,109 | +186.4% | 0.10% | +71.7% |
Q4 2021 | $476,000 | +6.2% | 40,885 | +104.4% | 0.06% | -20.0% |
Q3 2020 | $448,000 | – | 20,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |